Check out the companies making the biggest moves midday: Nike – Shares of the sneaker giant rose around 4% after board members Tim Cook and Robert Holmes Swan, as well as Nike CEO Elliott Hill, increased their stakes, Verity data shows. The action comes as Nike wraps up a tough year. Corcept Therapeutics – Shares plummeted 50% after the U.S. Food and Drug Administration did not approve of Corcept’s drug relacorilant as a treatment for patients with hypercortisolism. The FDA decided it couldn’t reach a favorable benefit-risk assessment for the drug without the company providing further evidence of effectiveness. Molina Healthcare — The insurer rose 2.7%, putting it on track for its fourth straight positive session and up 6.3% for the week. Molina got a boost this week after famed investor Michael Burry highlighted the company in a Substack post. Nvidia — The chipmaker rose 0.7%, adding to its stellar year of gains. For 2025, Nvidia is up 40%. Vanda Pharmaceuticals — The biopharma company surged 25% after the FDA approved tradipitant, a drug aimed at treating vomiting induced by motion. Taiwan Semiconductor Manufacturing — Shares ticked up 2% after Reuters reported that Nvidia asked the semiconductor firm to boost its H200 production in response to Chinese orders exceeding two million units for 2026. Hyatt Hotels — The hotel chain dropped more than 1% after updating its 2025 outlook due to Hurricane Melissa, which struck Jamaica in October. The company said it expects adjusted EBITDA to be at the low end of a $1.09 billion-$1.11 billion range. — CNBC’s Darla Mercado, Liz Napolitano and Alex Harring contributed reporting.
